199 related articles for article (PubMed ID: 31644971)
1. Advances and challenges in precision medicine in salivary gland cancer.
Lassche G; van Boxtel W; Ligtenberg MJL; van Engen-van Grunsven ACH; van Herpen CML
Cancer Treat Rev; 2019 Nov; 80():101906. PubMed ID: 31644971
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland tumors: Molecular characterization and therapeutic advances for metastatic disease.
Schvartsman G; Pinto NA; Bell D; Ferrarotto R
Head Neck; 2019 Jan; 41(1):239-247. PubMed ID: 30552848
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Salivary Gland Cancer and Treatment of Salivary Gland Cancers.
Palsgrove D; Allahabadi S; Khan SA
Surg Pathol Clin; 2021 Mar; 14(1):151-163. PubMed ID: 33526219
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract][Full Text] [Related]
5. New concepts of personalized therapy in salivary gland carcinomas.
Keller G; Steinmann D; Quaas A; Grünwald V; Janssen S; Hussein K
Oral Oncol; 2017 May; 68():103-113. PubMed ID: 28325631
[TBL] [Abstract][Full Text] [Related]
6. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S; Platini F; Bergamini C; Resteghini C; Galbiati D; Bossi P; Perrone F; Tamborini E; Quattrone P; Licitra L; Locati LD; Alfieri S
Expert Opin Investig Drugs; 2019 May; 28(5):435-443. PubMed ID: 30897975
[TBL] [Abstract][Full Text] [Related]
7. Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies.
Witte HM; Gebauer N; Steinestel K
Crit Rev Oncol Hematol; 2022 Feb; 170():103592. PubMed ID: 35026433
[TBL] [Abstract][Full Text] [Related]
8. Salivary Gland Neoplasms: Does Morphological Diversity Reflect Tumor Heterogeneity.
Rito M; Fonseca I
Pathobiology; 2018; 85(1-2):85-95. PubMed ID: 28930752
[TBL] [Abstract][Full Text] [Related]
9. Management of salivary gland carcinomas - a review.
Wang X; Luo Y; Li M; Yan H; Sun M; Fan T
Oncotarget; 2017 Jan; 8(3):3946-3956. PubMed ID: 27992367
[TBL] [Abstract][Full Text] [Related]
10. [Salivary gland cancer: new therapeutic approaches].
Herrera Gomez RG; Mederos N; Szturz P; Degrauwe N; Jankovic J; Cristina V
Rev Med Suisse; 2023 May; 19(827):958-963. PubMed ID: 37195109
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy for salivary gland malignancy: current status and future perspectives.
Imamura Y; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Yokota T; Okano S; Tanaka K; Onoe T; Ariizumi Y; Homma A
Jpn J Clin Oncol; 2022 Apr; 52(4):293-302. PubMed ID: 35134985
[TBL] [Abstract][Full Text] [Related]
12. A molecular guide to systemic therapy in salivary gland carcinoma.
Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
[TBL] [Abstract][Full Text] [Related]
13. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in salivary gland cancers.
Yin LX; Ha PK
Cancer; 2016 Jun; 122(12):1822-31. PubMed ID: 26928905
[TBL] [Abstract][Full Text] [Related]
15. New approaches in salivary gland carcinoma.
Even C; Baste N; Classe M
Curr Opin Oncol; 2019 May; 31(3):169-174. PubMed ID: 30844885
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
Sawabe M; Ito H; Takahara T; Oze I; Kawakita D; Yatabe Y; Hasegawa Y; Murakami S; Matsuo K
Cancer; 2018 Jan; 124(1):118-124. PubMed ID: 28881386
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
18. Salivary Gland Cancers: Biology and Systemic Therapy.
Goyal G; Mehdi SA; Ganti AK
Oncology (Williston Park); 2015 Oct; 29(10):773-80. PubMed ID: 26470903
[TBL] [Abstract][Full Text] [Related]
19. Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Thorpe LM; Schrock AB; Erlich RL; Miller VA; Knost J; Le-Lindqwister N; Jujjavarapu S; Ali SM; Liu JJ
Head Neck; 2017 Mar; 39(3):E40-E44. PubMed ID: 28006087
[TBL] [Abstract][Full Text] [Related]
20. Impact of tumour profiling on clinical trials in salivary gland cancer.
Rack S; Rahman R; Carter L; McKay C; Metcalf R
Clin Otolaryngol; 2019 Jan; 44(1):1-6. PubMed ID: 30102009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
